Kimberly-Clark Corporation(KMB)- NYSE
  • Wed, Jul. 20, 8:48 AM
    • Unilever (UL, UN) confirms it acquired Dollar Shave Club. The company didn't disclose the transaction price, but earlier reports pegged it at $1B which would make the deal the third largest buyout in the e-commerce space ever after Zulilly and Wayfair. The transaction is also an exclamation point on the disruption that Dollar Shave Club achieved in a consumer products category once considered nearly impenetrable.
    • The innovative shaving club sends razors directly to members for as little as $1 per month. Dollar Shave Club is on track to top $200M in turnover this year and has 3.2M members.
    • Earlier this week, news broke that Procter & Gamble (NYSE:PG) is increasing its testing of online subscriptions. It's a trend to watch for Colgate-Palmolive (NYSE:CL), Kimberly-Clark (NYSE:KMB), and Edgewell Personal Care (NYSE:EPC).
    • Previously: Fortune: Unilever buys Dollar Shave Club for $1B (July 20)
    | Wed, Jul. 20, 8:48 AM | 11 Comments
  • Oct. 23, 2015, 8:22 AM
    • Kimberly-Clark (NYSE:KMB) is in talks to acquire the diaper business of Hypermarcas (OTCPK:HYPMY), according to Reuters.
    • A deal announcement is expected within a few days.
    • The diaper business generated about 860M reais ($220.9M) last year.
    | Oct. 23, 2015, 8:22 AM | 3 Comments
  • Apr. 2, 2013, 12:47 PM

    Kimberly-Clark (KMB +1.7%) moves up after saying it's acquired the anesthesia business of Life-Tech, a Texas-based medical device manufacturer. The acquisition consists of needles, catheters and accessories associated with peripheral nerve block procedures, and the assets will become part of KMB's Health Care business and added to K-C Health Care's ON-Q family of products.

    | Apr. 2, 2013, 12:47 PM
  • May 10, 2012, 11:39 AM
    Kimberly Clark (KMB) is among the tentative bidders for German bandages maker BSN Medical, which is being sold by P-E firm Montagu, Reuters reports. Kimberly's competition includes rival ConvaTec as well as P-E companies EQT and Permira, with offers ranging from €1.6B-€1.8B ($2.1B-$2.3B).
    | May 10, 2012, 11:39 AM
  • Jul. 15, 2011, 4:50 PM
    Chris Stuart questions whether Clorox (CLX +8.9%) is really worth $100/share, as Carl Icahn claims it would be to a potential acquirer such PGUL, CL, or KMB. At $100, Clorox, which recently forecast FY2012 growth of just 1-3%, would trade at nearly 25x its estimated FY2012 EPS.
    | Jul. 15, 2011, 4:50 PM | 1 Comment
  • Jul. 15, 2011, 6:25 AM

    Icahn notes Clorox (CLX) "will not come close" to meeting sales growth forecasts of 3-5%/year. His offer is an attempt to prod CLX to pursue a deal with a "strategic buyer" (PG, UN, CL, KMB, Reckitt Benckiser, Henkel) - who Icahn believes will pay a higher price. "Quite simply, there are few strategic opportunities like Clorox."

    | Jul. 15, 2011, 6:25 AM | 1 Comment